Product Information

SUMATRIPTAN 20 MG NASAL SPRAY is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $15.2516 per EA under NDC 45802059806. Its NADAC has been published 311 times since Dec 9, 2020.

FDA first approved this application on Sep 21, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SUMATRIPTAN 20 MG NASAL SPRAY

sumatriptan
$15.2516per EA

Strength

20 mg/1

NDC

45802059806

Classification

Generic

Dosage Form

SPRAY

Route

NASAL

Effective Date

11/18/2026

Active Ingredients

SUMATRIPTAN

Approval Type

Generic (ANDA)

FDA Application

ANDA213465

FDA Approved

9/21/2020

TE Code

AB

On Market Since

10/4/2020

Pharmacological Classes

Serotonin 1b Receptor Agonists
Serotonin 1d Receptor Agonists
Serotonin-1b and Serotonin-1d Receptor Agonist

Price Statistics

The NADAC for SUMATRIPTAN 20 MG NASAL SPRAY has been published 311 times since Dec 9, 2020, and over the history we have for it it has declined 64.8%. The table below summarizes its recorded NADAC range and movement.

Current price$15.2516 per EA
All-time high$45.7134 (Jan 13, 2021)
All-time low$13.8657 (Nov 20, 2024)
52-week high$16.8906
52-week low$15.2516
Median price$19.3706
Average price$22.3070
Largest weekly change-38.3% (Nov 20, 2024)
Weeks tracked311
Tracking sinceDec 9, 2020

Price History

1W

-2.4%

1M

-7.6%

3M

-9.7%

6M

-5.1%

1Y

-4.4%

3Y

-12.5%

5Y

-53.1%

All

-64.8%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of SUMATRIPTAN 20 MG NASAL SPRAY?

The current National Average Drug Acquisition Cost (NADAC) for SUMATRIPTAN 20 MG NASAL SPRAY, manufactured by Padagis Israel Pharmaceuticals Ltd, is $15.2516 per EA (NDC 45802059806), effective Nov 18, 2026.

How has the price of SUMATRIPTAN 20 MG NASAL SPRAY changed over time?

Over the history we have for it, the NADAC for SUMATRIPTAN 20 MG NASAL SPRAY has declined 64.8%. It has been tracked across 311 weekly CMS publications since Dec 9, 2020.

What are the highest and lowest recorded NADAC prices for SUMATRIPTAN 20 MG NASAL SPRAY?

Since Dec 9, 2020, the NADAC for SUMATRIPTAN 20 MG NASAL SPRAY has ranged from a low of $13.8657 (Nov 20, 2024) to a high of $45.7134 (Jan 13, 2021), with a median of $19.3706 per EA.

Are there cheaper alternatives to SUMATRIPTAN 20 MG NASAL SPRAY?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SUMATRIPTAN 20 MG NASAL SPRAY in a comparable dosage form, but none are currently priced below it.

Who manufactures SUMATRIPTAN 20 MG NASAL SPRAY?

SUMATRIPTAN 20 MG NASAL SPRAY (NDC 45802059806) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.